Scancell receives approval to expand ModiFY cancer trial : c

Scancell receives approval to expand ModiFY cancer trial

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to expand its ModiFY...

Related Keywords

Lindy Durrant , Healthcare Products Regulatory Agency , Scancell Holdings , Professor Lindy ,

© 2024 Vimarsana